Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial

Volume: 20, Issue: 11, Pages: 1591 - 1600
Published: Sep 21, 2018
Abstract
Aims Decisive evidence on the optimal diuretic agent, dosing schedule, and administration route is lacking in acute heart failure (AHF) with congestion. The Acetazolamide in Decompensated heart failure with Volume OveRload (ADVOR) trial is designed to test the hypothesis that the carbonic anhydrase inhibitor acetazolamide, a potent inhibitor of proximal tubular sodium reabsorption, improves decongestion when combined with loop diuretic therapy...
Paper Details
Title
Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial
Published Date
Sep 21, 2018
Volume
20
Issue
11
Pages
1591 - 1600
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.